NEKTAR REPORTS THAT PFIZER TO INTRODUCE EXUBERA IN U.S. WITH A COMPREHENSIVE EDUCATION PROGRAM

Nektar Therapeutics reported that Pfizer Inc announced that Pfizer will introduce Exubera (insulin human (rDNA origin)) Inhalation Powder in the U.S. by commencing a comprehensive physician and patient education and training program for this landmark innovation in diabetes treatment on July 24, 2006, that will be rolled out in phases. Pfizer also said that initial supplies of Exubera will be available across the U.S. beginning in September. Exubera is marketed by Pfizer and is a product of a developmental collaboration between Pfizer and Nektar.
Genetic Engineering News